Human CXCL17/VCC-1 Antibody, R&D Systems™

CXCL17/VCC-1

Monoclonal

LYOPH

Western Blot 1 ug/mL, Intracellular Staining by Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready

Q6UXB2

CXCL17

E. coli-derived recombinant human CXCL17/VCC-1 Leu24-Leu119 Accession # Q6UXB2

25 μg

Primary

Detects human CXCL17/VCC-1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 25% cross-reactivity with recombinant mouse CXCL17 is observed.

Human

Purified

Western Blot, Flow Cytometry, Immunocytochemistry, CyTOF

422208

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Chemokine (C-X-C Motif) Ligand 17, C-X-C Motif Chemokine 17, CXCL17, Dcip1, Dendritic Cell And Monocyte Chemokine-Like Protein, DMC, UNQ473, VCC1, VCC-1, VEGF Coregulated Chemokine 1, VEGF Co-Regulated Chemokine 1

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

284340

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2b